Release 5 Draft Ballot

This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions Value Set

Public Health and Emergency Response Work Group Maturity Level: 1Draft Use Context: Not Intended for Production use

This is a value set defined by the FHIR project.


Defining URL:
Title:Vaccine Administered Value Set

This identifies the vaccine substance administered - CVX codes.

Committee:Public Health and Emergency Response Work Group
OID:2.16.840.1.113883. (for OID based terminology systems)
Source ResourceXML / JSON

This value set is used in the following places:

This value set includes codes based on the following rules:


This expansion generated 18 May 2022

This value set contains 287 concepts

Expansion based on version 20210406

CodeSystemDisplayEnglish (English, en)
54 vaccine, type 4, live, oraladenovirus, type 4
55 vaccine, type 7, live, oraladenovirus, type 7
82 vaccine, unspecified formulationadenovirus, unspecified formulation
24 vaccineanthrax
19 Calmette-Guerin vaccineBCG
27 antitoxin
26 vaccine, unspecified formulationcholera, unspecified formulation
29 immune globulin, intravenousCMVIG
56 fever vaccinedengue fever
12 antitoxin
28 and tetanus toxoids, adsorbed for pediatric useDT (pediatric)
20, tetanus toxoids and acellular pertussis vaccineDTaP
106, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigensDTaP, 5 pertussis antigens
107, tetanus toxoids and acellular pertussis vaccine, unspecified formulationDTaP, unspecified formulation
110 B and poliovirus vaccineDTaP-Hep B-IPV
50 influenzae type b conjugate vaccineDTaP-Hib
120, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)DTaP-Hib-IPV
130, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivatedDTaP-IPV
01, tetanus toxoids and pertussis vaccineDTP
22 influenzae type b conjugate vaccineDTP-Hib
102 Haemophilus influenzae type b conjugate and hepatitis b vaccineDTP-Hib-Hep B
57 vaccinehantavirus
52 A vaccine, adult dosageHep A, adult
83 A vaccine, pediatric/adolescent dosage, 2 dose scheduleHep A, ped/adol, 2 dose
84 A vaccine, pediatric/adolescent dosage, 3 dose scheduleHep A, ped/adol, 3 dose
31 A vaccine, pediatric dosage, unspecified formulationHep A, pediatric, unspecified formulation
85 A vaccine, unspecified formulationHep A, unspecified formulation
104 A and hepatitis B vaccineHep A-Hep B
30 B immune globulinHBIG
08 B vaccine, pediatric or pediatric/adolescent dosageHep B, adolescent or pediatric
42 B vaccine, adolescent/high risk infant dosageHep B, adolescent/high risk infant
43 B vaccine, adult dosageHep B, adult
44 B vaccine, dialysis patient dosageHep B, dialysis
45 B vaccine, unspecified formulationHep B, unspecified formulation
58 C vaccineHep C
59 E vaccineHep E
60 simplex virus, type 2 vaccineherpes simplex 2
46 influenzae type b vaccine, PRP-D conjugateHib (PRP-D)
47 influenzae type b vaccine, HbOC conjugateHib (HbOC)
48 influenzae type b vaccine, PRP-T conjugateHib (PRP-T)
49 influenzae type b vaccine, PRP-OMP conjugateHib (PRP-OMP)
17 influenzae type b vaccine, conjugate unspecified formulationHib, unspecified formulation
51 influenzae type b conjugate and Hepatitis B vaccineHib-Hep B
61 immunodeficiency virus vaccineHIV
118 papilloma virus vaccine, bivalentHPV, bivalent
62 papilloma virus vaccine, quadrivalentHPV, quadrivalent
86 globulin, intramuscularIG
87 globulin, intravenousIGIV
14 globulin, unspecified formulationIG, unspecified formulation
111 virus vaccine, live, attenuated, for intranasal useinfluenza, live, intranasal
15 virus vaccine, split virus (incl. purified surface antigen)-retired CODEinfluenza, split (incl. purified surface antigen)
16 virus vaccine, whole virusinfluenza, whole
88 virus vaccine, unspecified formulationinfluenza, unspecified formulation
123 virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile)influenza, H5N1-1203
10 vaccine, inactivatedIPV
02 poliovirus vaccine, live, oralOPV
89 vaccine, unspecified formulationpolio, unspecified formulation
39 Encephalitis Vaccine SCJapanese encephalitis SC
63 virus vaccineJunin virus
64 vaccineleishmaniasis
65 vaccineleprosy
66 disease vaccineLyme disease
03, mumps and rubella virus vaccineMMR
04 and rubella virus vaccineM/R
94, mumps, rubella, and varicella virus vaccineMMRV
67 vaccinemalaria
05 virus vaccinemeasles
68 vaccinemelanoma
32 polysaccharide vaccine (MPSV4)meningococcal MPSV4
103 C conjugate vaccinemeningococcal C conjugate
114 polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P)meningococcal MCV4P
108 ACWY vaccine, unspecified formulationmeningococcal ACWY, unspecified formulation
07 virus vaccinemumps
69 virus vaccineparainfluenza-3
11 vaccinepertussis
23 vaccineplague
33 polysaccharide vaccine, 23 valentpneumococcal polysaccharide PPV23
100 conjugate vaccine, 7 valentpneumococcal conjugate PCV 7
109 vaccine, unspecified formulationpneumococcal, unspecified formulation
70 fever vaccineQ fever
18 vaccine, for intramuscular injection RETIRED CODErabies, intramuscular injection
40 vaccine, for intradermal injectionrabies, intradermal injection
90 vaccine, unspecified formulationrabies, unspecified formulation
72 fever vaccinerheumatic fever
73 Valley fever vaccineRift Valley fever
34 immune globulinRIG
119, live, monovalent vaccinerotavirus, monovalent
122 vaccine, unspecified formulationrotavirus, unspecified formulation
116, live, pentavalent vaccinerotavirus, pentavalent
74, live, tetravalent vaccinerotavirus, tetravalent
71 syncytial virus immune globulin, intravenousRSV-IGIV
93 syncytial virus monoclonal antibody (palivizumab), intramuscularRSV-MAb
06 virus vaccinerubella
38 and mumps virus vaccinerubella/mumps
76 bacteriophage lysateStaphylococcus bacterio lysate
113 and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed
09 and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid)Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed
115 toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbedTdap
35 toxoid, adsorbed
112 toxoid, unspecified formulation
77 encephalitis vaccinetick-borne encephalitis
13 immune globulinTIG
95 skin test; old tuberculin, multipuncture deviceTST-OT tine test
96 skin test; purified protein derivative solution, intradermalTST-PPD intradermal
97 skin test; purified protein derivative, multipuncture deviceTST-PPD tine test
98 skin test; unspecified formulationTST, unspecified formulation
78 vaccine
91 vaccine, unspecified formulationtyphoid, unspecified formulation
25 vaccine, live, oraltyphoid, oral
41 vaccine, parenteral, other than acetone-killed, driedtyphoid, parenteral
53 vaccine, parenteral, acetone-killed, dried (U.S. military)typhoid, parenteral, AKD (U.S. military)
101 Vi capsular polysaccharide vaccinetyphoid, ViCPs
75 (smallpox) vaccinevaccinia (smallpox)
105 (smallpox) vaccine, dilutedvaccinia (smallpox) diluted
79 immune globulin
21 virus vaccinevaricella
81 equine encephalitis, inactivatedVEE, inactivated
80 equine encephalitis, live, attenuatedVEE, live
92 equine encephalitis vaccine, unspecified formulationVEE, unspecified formulation
36 zoster immune globulinVZIG
117 zoster immune globulin (Investigational New Drug)VZIG (IND)
37 fever vaccineyellow fever
121 vaccine, livezoster live
998 vaccine administered
999 vaccine or immune globulinunknown
99 - do not use
133 conjugate vaccine, 13 valentPneumococcal conjugate PCV 13
134 Encephalitis vaccine for intramuscular administrationJapanese Encephalitis IM
137, unspecified formulation
136 oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O)Meningococcal MCV4O
135, high dose seasonal, preservative-freeInfluenza, high dose seasonal
131 record of a typhus vaccinationtyphus, historical
132 diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine.DTaP-IPV-HIB-HEP B, historical
128 influenza-H1N1-09, all formulationsNovel Influenza-H1N1-09, all formulations
125 Influenza-H1N1-09, live virus for nasal administrationNovel Influenza-H1N1-09, nasal
126 influenza-H1N1-09, preservative-free, injectableNovel influenza-H1N1-09, preservative-free
127 influenza-H1N1-09, injectableNovel influenza-H1N1-09
138 and diphtheria toxoids, not adsorbed, for adult useTd (adult)
139 unspecified formulation
140, seasonal, injectable, preservative free
129 Encephalitis vaccine, unspecified formulationJapanese Encephalitis, unspecified formulation
141, seasonal, injectable
142 toxoid, not adsorbed
143, type 4 and type 7, live, oralAdenovirus types 4 and 7
144 influenza, intradermal, preservative freeinfluenza, seasonal, intradermal, preservative free
145 syncytial virus monoclonal antibody (motavizumab), intramuscularRSV-MAb (new)
146 and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine.DTaP,IPV,Hib,HepB
147, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135)meningococcal MCV4, unspecified formulation
148 Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate VaccineMeningococcal C/Y-HIB PRP
149, live, intranasal, quadrivalent
150, injectable, quadrivalent, preservative freeinfluenza, injectable, quadrivalent, preservative free
151 nasal, unspecified formulation
152 Conjugate, unspecified formulation
153, injectable, Madin Darby Canine Kidney, preservative freeInfluenza, injectable, MDCK, preservative free
154 A immune globulinHep A, IG
155, trivalent, recombinant, injectable influenza vaccine, preservative freeinfluenza, recombinant, injectable, preservative free
156 Immune globulin- IV or IMRho(D)-IG
157 Immune globulin - IMRho(D) -IG IM
158, injectable, quadrivalent, contains preservativeinfluenza, injectable, quadrivalent
159 Unspecified formulationRho(D) - Unspecified formulation
160 A monovalent (H5N1), adjuvanted, National stockpile 2013Influenza A monovalent (H5N1), ADJUVANTED-2013
801 Adjuvant
161, injectable,quadrivalent, preservative free, pediatric
162 B vaccine, fully recombinantmeningococcal B, recombinant
163 B vaccine, recombinant, OMV, adjuvantedmeningococcal B, OMV
164 B, unspecified formulationmeningococcal B, unspecified
165 Papillomavirus 9-valent vaccineHPV9
166, intradermal, quadrivalent, preservative free, injectableinfluenza, intradermal, quadrivalent, preservative free
167 vaccine of unknown formulation and unknown serogroupsmeningococcal, unknown serogroups
168 trivalent influenza vaccine, adjuvanted, preservative freeinfluenza, trivalent, adjuvanted
169 A, live attenuated-IMHep A, live attenuated
170 diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV)DTAP/IPV/HIB - non-US
171, injectable, Madin Darby Canine Kidney, preservative free, quadrivalentInfluenza, injectable, MDCK, preservative free, quadrivalent
172, WC-rBS
173, BivWC
174, live attenuated
175 Rabies vaccine from human diploid cell cultureRabies - IM Diploid cell culture
176 rabies vaccine from Chicken fibroblast cultureRabies - IM fibroblast culture
177 conjugate vaccine, 10 valentPCV10
178 bivalent oral polio vaccine (types 1 and 3)OPV bivalent
179 monovalent oral polio vaccine, unspecified formulationOPV ,monovalent, unspecified
180 immune globulin
181 immune globulin
182 Polio Vaccine, Unspecified formulationOPV, Unspecified
183 fever vaccine alternative formulationYellow fever vaccine - alt
184 fever vaccine, unspecified formulationYellow fever, unspecified formulation
185, quadrivalent, recombinant, injectable influenza vaccine, preservative freeinfluenza, recombinant, quadrivalent,injectable, preservative free
186, injectable, Madin Darby Canine Kidney, quadrivalent with preservativeInfluenza, injectable, MDCK, quadrivalent, preservative
187 vaccine recombinantzoster recombinant
188 vaccine, unspecified formulationzoster, unspecified formulation
189 B vaccine (recombinant), CpG adjuvantedHepB-CpG
190 conjugate vaccine (non-US)Typhoid conjugate vaccine (TCV)
191 A polysaccharide vaccine (non-US)meningococcal A polysaccharide (non-US)
192 AC polysaccharide vaccine (non-US)meningococcal AC polysaccharide (non-US)
193 A and hepatitis B vaccine, pediatric/adolescent (non-US)Hep A-Hep B, pediatric/adolescent
194, Southern Hemisphere, unspecified formulationInfluenza, Southern Hemisphere
195, Tetanus, Poliomyelitis adsorbedDT, IPV adsorbed
196 and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecifiedTd, adsorbed, preservative free, adult use, Lf unspecified
197, high-dose seasonal, quadrivalent, .7mL dose, preservative freeinfluenza, high-dose, quadrivalent
200, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative freeinfluenza, Southern Hemisphere, pediatric, preservative free
201, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservativeinfluenza, Southern Hemisphere, preservative free
202, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservativeinfluenza, Southern Hemisphere, quadrivalent, with preservative
198, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent)DTP-hepB-Hib Pentavalent Non-US
203 polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine .5mL dose, preservative freemeningococcal polysaccharide (groups A, C, Y, W-135) TT conjugate
205, seasonal vaccine, quadrivalent, adjuvanted, .5mL dose, preservative freeInfluenza vaccine, quadrivalent, adjuvanted
206 monkeypox vaccine, live attenuated, preservative free (National Stockpile)Smallpox monkeypox vaccine (National Stockpile)
207 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL doseCOVID-19, mRNA, LNP-S, PF, 100 mcg/0.5 mL dose
208 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL doseCOVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose
213 (COVID-19) vaccine, UNSPECIFIED
210 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mLCOVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL
212 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mlCOVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL
204 Zaire vaccine, live, recombinant, 1mL dose
214, unspecified
211 (COVID-19) vaccine, Subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL per doseCOVID-19 vaccine, Subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL
DTPurn:oid: Antigen
ENGPurn:oid: B
FVXJNRurn:oid: Junior
GNHEPurn:oid: B
GNHPAurn:oid: A
GNJENurn:oid: Encephalitis
GNMENurn:oid: C
HATWNJurn:oid: Junior
HAVAQurn:oid: Paed/Adol
HAVJurn:oid: Junior
HBVPurn:oid: II
IFHXurn:oid: Hexa
IFPAurn:oid: Penta
MMRCSLurn:oid: II
PRVNRurn:oid: 7
PRVTHurn:oid: 13
VGRJNRurn:oid: Junior


See the full registry of value sets defined as part of FHIR.

Explanation of the columns that may appear on this page:

LvlA few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information
SourceThe source of the definition of the code (when the value set draws in codes defined elsewhere)
CodeThe code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract')
DisplayThe display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
DefinitionAn explanation of the meaning of the concept
CommentsAdditional notes about how to use the code